MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 15, 2007; DOI: 10.1124/mol.106.032458


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.106.032458v1
72/2/407    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perez-Ortiz, J. M
Right arrow Articles by Llopis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perez-Ortiz, J. M
Right arrow Articles by Llopis, J.


Received for publication November 8, 2006.
Revised May 12, 2007.
Accepted for publication May 15, 2007.

GLITAZONES INDUCE ASTROGLIOMA CELL DEATH BY RELEASING REACTIVE OXYGEN SPECIES FROM MITOCHONDRIA: MODULATION OF CYTOTOXICITY BY NITRIC OXIDE

Jose M Perez-Ortiz 1, Pedro Tranque 1, Miguel Burgos 1, Cecilia F Vaquero 1, Juan Llopis 1*

1 School of Medicine, University of Castilla-La Mancha

* Address correspondence to: E-mail: juan.llopis{at}uclm.es

Abstract

The glitazones (or thiazolidinediones) are synthetic compounds used in type-2 diabetes, but they also have broad anti-proliferative and anti-inflammatory properties still not well understood. Previously we described the apoptotic effects of glitazones on astroglioma cells (J. Biol. Chem., 279, 8976-8985). At certain concentrations, we found a selective lethality on glioma cells versus astrocytes, which was dependent on a rapid production of reactive oxygen species (ROS) and seemed unrelated to the receptor PPAR{gamma}. The present study was aimed at characterizing the oxygen derivatives induced by ciglitazone, rosiglitazone and pioglitazone in C6 glioma cells and to investigate their intracellular source. We examined the interaction of ROS with nitric oxide (NO) and its consequences for glioma cell survival. Fluorescence microscopy and flow cytometry showed that glitazones induced superoxide anion, peroxynitrite and hydrogen peroxide, ciglitazone being the most active. ROS production was completely prevented by uncoupling of the electron transport chain and by removal of glucose as energy substrate, whereas it was unaffected by inhibition of NADPH-oxidase and xanthine-oxidase. Moreover, glitazones inhibited state 3 respiration in permeabilized cells, and experiments with mitochondrial inhibitor suggested that Complex-I was the likely target of glitazones. Therefore, these results point to the mitochondrial electron transport chain as the source of glitazone-induced ROS in C6 cells. Glitazones also depolarized mitochondria and reduced mitochondrial pH. NO synthase inhibitors revealed that superoxide anion combines with NO to yield peroxynitrite, and that the latter contributes to the cytotoxicity of glitazones in astroglioma cells. Future anti-tumoral strategies may take advantage of these findings.


Key words: Nitric oxide synthases, PPARs, Fluorescence techniques, Mitochondrial toxins, Reactive intermediates, Mechanisms of cell killing/apoptosis


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Hou, R. Liu, S. Ross, E. J. Smart, H. Zhu, and W. Gong
Crystallographic Studies of Human MitoNEET
J. Biol. Chem., November 16, 2007; 282(46): 33242 - 33246.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics